Guggenheim Capital’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Guggenheim Capital’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-9,617	Closed	-$1.57M	–	2941
2016 Q1	$1.57M	Sell	9,617 -729	-7%	-$148K	0.01%	1737
2015 Q4	$3.39M	Sell	10,346 -1,512	-13%	-$492K	0.01%	1244
2015 Q3	$3.83M	Sell	11,858 -1,965	-14%	-$863K	0.01%	1176
2015 Q2	$5.51M	Buy	13,823 +3,514	+34%	+$1.49M	0.01%	1107
2015 Q1	$5.08M	Sell	10,309 -335	-3%	-$130K	0.01%	1157
2014 Q4	$3.81M	Buy	10,644 +611	+6%	+$182K	0.01%	1280
2014 Q3	$1.93M	Sell	10,033 -544	-5%	-$120K	﹤0.01%	1783
2014 Q2	$2.53M	Sell	10,577 -1,018	-9%	-$207K	0.01%	1619
2014 Q1	$2.96M	Buy	+11,595	New	+$3.54M	0.01%	1460

Other funds holding LUMO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

TAM

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Guggenheim Capital's LUMO Position: Q2 2016 in Review

Guggenheim Capital sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2016, closing a stake of 9,617 shares — an estimated $1.57M sold.

Guggenheim Capital first reported a position in LUMO in Q1 2014 and held it in 9 quarters. The position peaked at $5.51M in Q2 2015. 112 funds tracked by Wall St. Rank hold LUMO as of Q2 2016.

Guggenheim Capital reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
Guggenheim Capital sold 9,617 Lumos Pharma, Inc. Common Stock shares in Q2 2016, an estimated $1.57M.
Guggenheim Capital first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2014 and held it in 9 quarters.
Guggenheim Capital's Lumos Pharma, Inc. Common Stock position peaked at $5.51M in Q2 2015.
112 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2016.

Based on Guggenheim Capital's 13F filing for Q2 2016, filed 15 Aug 2016.